04:54 PM EDT, 03/16/2026 (MT Newswires) -- CytomX Therapeutics ( CTMX ) said late Monday it has launched an underwritten public offering of shares to raise $250 million.

Investors can also buy pre-funded warrants in lieu, the company said. It also plans to grant its underwriters a 30-day option to buy up to an additional $37.5 million of shares.

Net proceeds will be used to advance Varseta-M, other pipeline programs, and for general corporate purposes, the firm said.